Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer

Berghmans T, Remmelink M, Awada A

Lung Cancer: Targets and Therapy 2012, 3:91-99

Published Date: 18 December 2012